Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.

[1]  M. Wilén,et al.  Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. , 1979, The American journal of medicine.

[2]  J. Franciosa,et al.  Immediate Effects of Hydralazine-Isosorbide Dinitrate Combination on Exercise Capacity and Exercise Hemodynamics in Patients with Left Ventricular Failure , 1979, Circulation.

[3]  J. Cohn,et al.  Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. , 1979, The American journal of cardiology.

[4]  B. Brundage,et al.  Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. , 1979, The American journal of cardiology.

[5]  W. Aronow,et al.  Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.

[6]  J. Cohn,et al.  Nitrate Therapy for Congestive Heart Failure , 1978 .

[7]  J. Cohn,et al.  Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure. , 1978, The American journal of medicine.

[8]  S. Epstein,et al.  Nitroglycerin-induced improvement in exercise tolerance and hemodynamics in patients with chronic rheumatic heart valve disease. , 1978, The American journal of cardiology.

[9]  W. Aronow,et al.  Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure. , 1977, The American journal of cardiology.

[10]  J. Cohn,et al.  Vasodilator therapy of cardiac failure (second of two parts). , 1977, The New England journal of medicine.

[11]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[12]  J. Longhurst,et al.  Cardiocirculatory responses to muscular exercise in congestive heart failure. , 1977, Progress in cardiovascular diseases.

[13]  J. Franciosa.  Evaluation of the CO2 Rebreathing Cardiac Output Method In Seriously III Patients , 1977, Circulation.

[14]  Franciosa Ja,et al.  Validation of the CO2 rebreathing method for measuring cardiac output in patients with hypertension or heart failure. , 1976 .

[15]  P. Barter,et al.  The transport of esterified cholesterol in plasma high density lipoproteins of human subjects: a mathematical model. , 1976, The Journal of laboratory and clinical medicine.

[16]  J. Holloszy.  Adaptations of muscular tissue to training. , 1976, Progress in cardiovascular diseases.

[17]  E. Alderman,et al.  Hemodynamic Consequences of Afterload Reduction in Patients with Chronic Aortic Regurgitation , 1976, Circulation.

[18]  J. Cohn,et al.  Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure , 1974, Circulation.

[19]  J. Longhurst,et al.  A Comparison of Regional Blood Flow and Oxygen Utilization During Dynamic Forearm Exercise in Normal Subjects and Patients with Congestive Heart Failure , 1974, Circulation.

[20]  W. Parmley,et al.  Beneficial Effects of Vasodilator Agents in Severe Mitral Regurgitation Due to Dysfunction of Subvalvar Apparatus , 1973, Circulation.

[21]  R. Zelis,et al.  Diminished Forearm Arteriolar Dilator Capacity Produced by Mineralocorticoid‐Induced Salt Retention in Man: Implications Concerning Congestive Heart Failure and Vascular Stiffness , 1970, Circulation.

[22]  S. Julius,et al.  Comparison of cardiac output determined by CO2 rebreathing and dye-dilution methods , 1968 .

[23]  K. Wasserman,et al.  CONTINUOUS MEASUREMENT OF VENTILATORY EXCHANGE RATIO DURING EXERCISE. , 1964, Journal of applied physiology.